VAS and functional score in all trials that we have analyzed. Conclusion: intra-articular injection with HA is effective in reducing pain and improving function in shoulder with rotator cuff tears and without severe adverse reaction. Level of evidence: Level I.
Material and methods

Criteria for consideration
We included randomized clinical trials, prospective and retrospective studies reporting on clinical and functional outcomes in patients who had undergone sub-acromial or intra-articular injections of HA for management of rotator cuff pathology. Given the linguistic capabilities of the research team, we considered only papers published in English language. We performed a broad search for relevant studies published up to August 2014 in Medline (http://www.ncbi.nlm.nih.gov/sites/entrez/); Ovid (http://www.ovid.com); Cochrane Reviews (http://www.cochrane.org/reviews/), Google Scholar, Enbase database. Combined key words for the search were "cuff tears", "glenohumeral", "hyaluronic acid", "hyaluronate", "shoulder", "viscosupplementation", with no limit for year of publication. We identified 178 publications. Two Authors (MB and ADB) reviewed the abstract of each publication, and selected or excluded the study according to the text of the abstract. The article was excluded if the abstract was not available. In addition, screening the reference lists of relevant studies, articles not identified at the first electronic search were included. All journals were considered, and all relevant articles were retrieved. Papers referring to a specific association between cuff disorders and obvious osteoarthritis of the shoulder were excluded. Biomechanical reports, studies on animals, cadavers, in vitro or animal studies, case reports, literature reviews, technical notes, letters to editors and instructional course were excluded. To qualify, an article would have to have been published in peer-reviewed journals. We obtained full-text versions of the study if the abstract did not allow to include or exclude it. All search steps, inclusion and exclusion criteria are reported in Figure 1 . 178 articles were identified and selected. 32 full-text selected articles were reviewed and discussed by all the Authors; a fully trained orthopedic surgeon with special interest in shoulder surgery and sports disorders (LO) took the final deci- 
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Outcome measures
Data were extracted from each study without contacting the Author(s) to verify the accuracy of the data or obtain further information. The visual analogue scale (VAS) assessment was considered as major criterion for clinical success. Data on range of motion (ROM) [19] [20] [21] [22] [23] [24] , Constant score [25] [26] [27] [28] , shoulder function assessment scale (SFA) and shoulder disability questionnaire (SDQ) 23 , short form-12(SF12) 24 , University of California at Los Angeles score (UCLA) 20 , Oxford Shoulder Score and Patient Global Assessment 29 , Shoulder Rating Questionnaires 27 , and activities of daily living (ADL) 28 were extracted for assessment of clinical and functional outcomes. Rates of complications were also extracted to assess the safety, effectiveness, and reliability of these procedures.
Results
Eleven studies have been published from 1995 to 2013, all reporting outcomes of patients who had undergone injections of HA for management of rotator cuff tears (Tab. 1). The number of patients varied from 22 27 to 602 24 , for a total number of 1102 patients. Specifically, 701 patients underwent intra-articular injections of HA, 236 underwent intra-articular injections of saline solution 21, 24, 26 , 53 underwent intra-articular injections of methylprednisolone acetate 20, 23 , and 35 patients underwent other physical therapies. Different types of HA were used, based on the low or medium molecular weight. The commercial name also differed: Hylan G-F 20 22 , Fermathron™ 26 , Hyruan Plus® 23 , SportVis™ 29 , Jointex 27 , Artz 25 were used in one study each, a not specified high weight HA 19, 20, 28 and Hyalgan 21,24 in 3 and 2 studies, respectively. The mean age of patients managed was 59.2 years. The numbers of injections varied: 2 in 1 studies 29 , 1 a week for five weeks in 5 studies [19] [20] [21] 24, 25 , one 23, 28 studies and 3 22, 24, 26, 27 in 4 studies. Intra-articular injection were undertaken in 5 studies 19, 20, 22, 24, 27 subacromial injections under US guidance were administered in seven studies 19, 21, 23, 25, 26, 28, 29 . The diagnosis of rotaror cuff tear was mainly on clinical examination, and confirmed at MRI or US scans. The main exclusion criteria were inflammatory arthritis, crystalline synovitis, avascular necrosis, rapidly progressive disease, history of sepsis, trauma, and previous surgery to the shoulder, intra-articular injections of corticosteroids to the shoulder at least 6 months before the treatment, neoplasm, and painful conditions to the cervical spine (Tab. 1).
The follow-up of each study, scores before and after management and adverse reactions are reported in Table 2 .
Complications
In all studies, no serious device-related adverse events were observed. A mild vagal reaction occurred in 1 of 30 patients (3%) 28 . In another study 7 patients (3.2%) in the five-injection hyaluronate group, 3 patients (1.4%) in the three-injection hyaluronate group, and 7 patients (1.4%) in the control group complained of persistent pain at the injection site 24 (Tab. 2). 
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Discussion
The main finding of the present study is that HA injections improve symptoms and function in patients with rotator cuff disorders, without side effects and reactions. On the hand, oral NSAIDs administrations and [30] [31] [32] such as diabetes or hypertension. In fact, the HA is physiologically present in the synovial fluid 33 : its main role is to lubrificate the joint, it exerts mechanical and biological functions, in terms of anti-adhesive shock absorber and articular stabilizer against shear stresses 34 , and it presents some analgesic effects 35 . The HA is a polymer of disaccharides, composed by Dglucuronic acid and D-N-acetyl-glucosamine, synthesized by a class of integral membrane proteins. It is present in the extracellular matrix, and is a biomechanical and functional element of the articular cartilage 36 . Specifically, the HA is viscoelastic, lubrificates and protects the articular surface and cartilage from stress and friction forces 37 . In vitro, HA reduces the gliding resistance after flexor tendon repair 38 . It has an anti-inflammatory role, mediated by the regulation of the concentration of prosta glandin E2, C4S and interleukin-1 within the synovial fluid, the migration of leukocyte, leukocyte phagocytosis, lymphocyte proliferation, improving significantly pain and discomfort 39, 40 . It reduces the concentration of interleukin-6, stimulates synovial fibroblasts to produce endogenous HA, and regulates the expression of endothelial growth factor and type IV collagen 16 (pro-angiogenic effect) 41 . In one in vivo study on sheep models, HA reduces synovial hyperplasia, inflammation, fibrosis and neovascularization after meniscectomy 42 , limiting the degeneration of cartilages. It was supposed to increase angiogenesis after removal of the anterior cruciate ligament in Wistar rats 43, 44 , and to decrease toll-like receptor 4 (TLR-4) and the TLR-2 expression (receptors that play an important role in the arthritis mechanism) in mouse 45 . This systematic review evaluates the effects of HA injections in patients with rotator cuff tears. Different scores and scales were used in the studies. The VAS score improved in all studies examinated in this review. In two studies 20, 23 comparing HA vs methylprednisolone acetate injections, better clinical results and symptoms were recorded after administration of HA. In particular, Byun 23 showed better results in terms of ROM, proving that HA may improve motion and function of the shoulder, especially in active internal rotation. Four studies 21, [24] [25] [26] comparing patients undergoing HA vs phosphate-buffered saline injections reported good clinical results and pain relief. In particular, Blaine 24 showed better ROM recovery, reduced pain at night, and significantly higher overall satisfaction in the HA group; Meloni 21 showed a significant difference in the improvement of clinical symptoms and recovery of functional status in patients at 1 month after the end of the HA infiltrative cycle, in particular HA group VAS score was 2.8 respect 8.0 in the sodium chloride solution group. Chou 25 and Moghtaderi showed a significantly improvement in Constant score and VAS scores at 12 weeks and 6 weeks, respectively. Two studies 22, 29 evaluated the use of HA compared to the use of physical therapies, concluding that HA injections are safe and effective for patients with rotator cuff pathology.
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There are several limitations to the present investigation. Specifically, few studies evaluated the effects of HA; and different clinical scores were used making it difficult to compare the results.
Conclusion
Intra-articular injections of HA are effective to reduce pain and improve the function of the shoulder in patients with rotator cuff pathology, with no severe complications or adverse reactions. It could be used as an alternative to cortisone or other oral drugs, exploiting its biomechanical and biochemical properties. Further randomized controlled studies are needed to better understand which is the most effective molecular weight of HA, how often and in which grade of lesions it should be injected.
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